✨ Medicines Approval




2122 NEW ZEALAND GAZETTE, No. 85 8 JULY 2004

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Fenpaed (pharmacy only)
Active Ingredient:
Ibuprofen 20mg/mL
Dosage Form:
Oral suspension
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland

Product:
Fenpaed (prescription)
Active Ingredient:
Ibuprofen 20mg/mL
Dosage Form:
Oral suspension
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland

Product:
Nurofen Caplet (general sale)
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
Boots Contract Manufacturing Limited, Beeston, Nottingham, England

Product:
Nurofen Liquid (general sale)
Active Ingredient:
Ibuprofen 200mg/dose
Dosage Form:
Liquid filled capsule
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
Banner Pharmacaps Europe BV, Tilburg, The Netherlands

Product:
Nurofen Migraine Pain (general sale)
Active Ingredient:
Ibuprofen lysinate 342mg equivalent to 200mg ibuprofen
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
Boots Contract Manufacturing Limited, Beeston, Nottingham, England

Product:
Nurofen Tablet (general sale)
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
Boots Contract Manufacturing Limited, Beeston, Nottingham, England

Product:
Panafen IB Caplets (general sale)
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia

Product:
Panafen IB (general sale)
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia

Product:
Panafen IB (pharmacy only)
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia

Product:
Stieprox Liquid
Active Ingredient:
Ciclopirox olamine 1.5%w/w
Dosage Form:
Shampoo
New Zealand Sponsor:
David Sparks Limited
Manufacturers:
Stiefel Laboratories (Ireland) Limited, Finisklin, Sligo, Ireland
Stiefel Laboratories Pte Limited, Jurong, Singapore

Dated this 29th day of June 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go4330



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 85


Gazette.govt.nz PDF NZ Gazette 2004, No 85





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
29 June 2004
Medicines Act, Ibuprofen, Fenpaed, Nurofen, Panafen IB, Stieprox Liquid
  • DON MATHESON, Deputy Director-General, Public Health